Skip to main content
Premium Trial:

Request an Annual Quote

Structural Genomix and Hereditary Disease Foundation Explore Huntington s Disease Protein

NEW YORK, Dec. 10-The San Diego company Structural GenomiX is starting a research collaboration with the Hereditary Disease Foundation to solve the structure of huntingtin, the protein associated with Huntington's Disease.

 

Structural GenomiX will use its structure determination methods, including protein crystallization and X-ray crystallography, to find out how 3-D modifications in the protein structure are involved in disease initiation and progression. The partners will also study the structure of the normal protein in order to understand its normal function.

 

Structural GenomiX will receive research funding, royalties, and payments at milestones.

 

HDF will attempt to identify drug candidates that interact with this protein as potential therapeutics for Huntington's Disease.

 

Huntington's Disease, caused by a mutation on the fourth chromosome, is a degenerative neurological disorder that causes severe cognitive problems and motor problems. Roughly 35,000 to 50,000 Americans have the disease, which is generally fatal.

 

The Hereditary Disease Foundation is a nonprofit organization dedicated to promoting biomedical research into genetic diseases.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.